ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dalfampridine Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-4Y8674
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dalfampridine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dalfampridine Market Insights, Forecast to 2030

Code: QYRE-Auto-4Y8674
Report
December 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma

Dalfampridine Market

Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. 
The global Dalfampridine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dalfampridine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dalfampridine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dalfampridine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Dalfampridine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dalfampridine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dalfampridine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dalfampridine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dalfampridine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dalfampridine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Dalfampridine Market Report

Report Metric Details
Report Name Dalfampridine Market
Segment by Type
  • 10 mg
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Sun Pharmaceutical, Aurobindo Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Dalfampridine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Dalfampridine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dalfampridine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dalfampridine Market report?

Ans: The main players in the Dalfampridine Market are Biogen, Sun Pharmaceutical, Aurobindo Pharma

What are the Application segmentation covered in the Dalfampridine Market report?

Ans: The Applications covered in the Dalfampridine Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Dalfampridine Market report?

Ans: The Types covered in the Dalfampridine Market report are 10 mg, Others

Recommended Reports

Neurology Treatments

Multiple Sclerosis Markets

API and Drug Markets

1 Study Coverage
1.1 Dalfampridine Product Introduction
1.2 Market by Type
1.2.1 Global Dalfampridine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 10 mg
1.2.3 Others
1.3 Market by Application
1.3.1 Global Dalfampridine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dalfampridine Sales Estimates and Forecasts 2019-2030
2.2 Global Dalfampridine Revenue by Region
2.2.1 Global Dalfampridine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dalfampridine Revenue by Region (2019-2024)
2.2.3 Global Dalfampridine Revenue by Region (2025-2030)
2.2.4 Global Dalfampridine Revenue Market Share by Region (2019-2030)
2.3 Global Dalfampridine Sales Estimates and Forecasts 2019-2030
2.4 Global Dalfampridine Sales by Region
2.4.1 Global Dalfampridine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dalfampridine Sales by Region (2019-2024)
2.4.3 Global Dalfampridine Sales by Region (2025-2030)
2.4.4 Global Dalfampridine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dalfampridine Sales by Manufacturers
3.1.1 Global Dalfampridine Sales by Manufacturers (2019-2024)
3.1.2 Global Dalfampridine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dalfampridine in 2023
3.2 Global Dalfampridine Revenue by Manufacturers
3.2.1 Global Dalfampridine Revenue by Manufacturers (2019-2024)
3.2.2 Global Dalfampridine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dalfampridine Revenue in 2023
3.3 Global Key Players of Dalfampridine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dalfampridine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dalfampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dalfampridine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dalfampridine, Product Offered and Application
3.8 Global Key Manufacturers of Dalfampridine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dalfampridine Sales by Type
4.1.1 Global Dalfampridine Historical Sales by Type (2019-2024)
4.1.2 Global Dalfampridine Forecasted Sales by Type (2025-2030)
4.1.3 Global Dalfampridine Sales Market Share by Type (2019-2030)
4.2 Global Dalfampridine Revenue by Type
4.2.1 Global Dalfampridine Historical Revenue by Type (2019-2024)
4.2.2 Global Dalfampridine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dalfampridine Revenue Market Share by Type (2019-2030)
4.3 Global Dalfampridine Price by Type
4.3.1 Global Dalfampridine Price by Type (2019-2024)
4.3.2 Global Dalfampridine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dalfampridine Sales by Application
5.1.1 Global Dalfampridine Historical Sales by Application (2019-2024)
5.1.2 Global Dalfampridine Forecasted Sales by Application (2025-2030)
5.1.3 Global Dalfampridine Sales Market Share by Application (2019-2030)
5.2 Global Dalfampridine Revenue by Application
5.2.1 Global Dalfampridine Historical Revenue by Application (2019-2024)
5.2.2 Global Dalfampridine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dalfampridine Revenue Market Share by Application (2019-2030)
5.3 Global Dalfampridine Price by Application
5.3.1 Global Dalfampridine Price by Application (2019-2024)
5.3.2 Global Dalfampridine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dalfampridine Market Size by Type
6.1.1 US & Canada Dalfampridine Sales by Type (2019-2030)
6.1.2 US & Canada Dalfampridine Revenue by Type (2019-2030)
6.2 US & Canada Dalfampridine Market Size by Application
6.2.1 US & Canada Dalfampridine Sales by Application (2019-2030)
6.2.2 US & Canada Dalfampridine Revenue by Application (2019-2030)
6.3 US & Canada Dalfampridine Market Size by Country
6.3.1 US & Canada Dalfampridine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dalfampridine Sales by Country (2019-2030)
6.3.3 US & Canada Dalfampridine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dalfampridine Market Size by Type
7.1.1 Europe Dalfampridine Sales by Type (2019-2030)
7.1.2 Europe Dalfampridine Revenue by Type (2019-2030)
7.2 Europe Dalfampridine Market Size by Application
7.2.1 Europe Dalfampridine Sales by Application (2019-2030)
7.2.2 Europe Dalfampridine Revenue by Application (2019-2030)
7.3 Europe Dalfampridine Market Size by Country
7.3.1 Europe Dalfampridine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dalfampridine Sales by Country (2019-2030)
7.3.3 Europe Dalfampridine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dalfampridine Market Size
8.1.1 China Dalfampridine Sales (2019-2030)
8.1.2 China Dalfampridine Revenue (2019-2030)
8.2 China Dalfampridine Market Size by Application
8.2.1 China Dalfampridine Sales by Application (2019-2030)
8.2.2 China Dalfampridine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dalfampridine Market Size by Type
9.1.1 Asia Dalfampridine Sales by Type (2019-2030)
9.1.2 Asia Dalfampridine Revenue by Type (2019-2030)
9.2 Asia Dalfampridine Market Size by Application
9.2.1 Asia Dalfampridine Sales by Application (2019-2030)
9.2.2 Asia Dalfampridine Revenue by Application (2019-2030)
9.3 Asia Dalfampridine Sales by Region
9.3.1 Asia Dalfampridine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dalfampridine Revenue by Region (2019-2030)
9.3.3 Asia Dalfampridine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dalfampridine Market Size by Type
10.1.1 Middle East, Africa and Latin America Dalfampridine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dalfampridine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dalfampridine Market Size by Application
10.2.1 Middle East, Africa and Latin America Dalfampridine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dalfampridine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dalfampridine Sales by Country
10.3.1 Middle East, Africa and Latin America Dalfampridine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dalfampridine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dalfampridine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Acorda Therapeutics
11.1.1 Acorda Therapeutics Company Information
11.1.2 Acorda Therapeutics Overview
11.1.3 Acorda Therapeutics Dalfampridine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Acorda Therapeutics Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Acorda Therapeutics Recent Developments
11.2 Elan Pharma
11.2.1 Elan Pharma Company Information
11.2.2 Elan Pharma Overview
11.2.3 Elan Pharma Dalfampridine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Elan Pharma Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elan Pharma Recent Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Overview
11.3.3 Biogen Dalfampridine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biogen Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Dalfampridine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharmaceutical Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Dalfampridine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Aurobindo Pharma Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dalfampridine Industry Chain Analysis
12.2 Dalfampridine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dalfampridine Production Mode & Process
12.4 Dalfampridine Sales and Marketing
12.4.1 Dalfampridine Sales Channels
12.4.2 Dalfampridine Distributors
12.5 Dalfampridine Customers
13 Market Dynamics
13.1 Dalfampridine Industry Trends
13.2 Dalfampridine Market Drivers
13.3 Dalfampridine Market Challenges
13.4 Dalfampridine Market Restraints
14 Key Findings in The Global Dalfampridine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
List of Tables
    Table 1. Global Dalfampridine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 10 mg
    Table 3. Major Manufacturers of Others
    Table 4. Global Dalfampridine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Dalfampridine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Dalfampridine Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Dalfampridine Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Dalfampridine Revenue Market Share by Region (2019-2024)
    Table 9. Global Dalfampridine Revenue Market Share by Region (2025-2030)
    Table 10. Global Dalfampridine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Dalfampridine Sales by Region (2019-2024) & (K Units)
    Table 12. Global Dalfampridine Sales by Region (2025-2030) & (K Units)
    Table 13. Global Dalfampridine Sales Market Share by Region (2019-2024)
    Table 14. Global Dalfampridine Sales Market Share by Region (2025-2030)
    Table 15. Global Dalfampridine Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Dalfampridine Sales Share by Manufacturers (2019-2024)
    Table 17. Global Dalfampridine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Dalfampridine Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Dalfampridine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Dalfampridine Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Dalfampridine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Dalfampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dalfampridine as of 2023)
    Table 23. Global Key Manufacturers of Dalfampridine, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Dalfampridine, Product Offered and Application
    Table 25. Global Key Manufacturers of Dalfampridine, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 28. Global Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 29. Global Dalfampridine Sales Share by Type (2019-2024)
    Table 30. Global Dalfampridine Sales Share by Type (2025-2030)
    Table 31. Global Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Dalfampridine Revenue Share by Type (2019-2024)
    Table 34. Global Dalfampridine Revenue Share by Type (2025-2030)
    Table 35. Dalfampridine Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Dalfampridine Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 38. Global Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 39. Global Dalfampridine Sales Share by Application (2019-2024)
    Table 40. Global Dalfampridine Sales Share by Application (2025-2030)
    Table 41. Global Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Dalfampridine Revenue Share by Application (2019-2024)
    Table 44. Global Dalfampridine Revenue Share by Application (2025-2030)
    Table 45. Dalfampridine Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Dalfampridine Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Dalfampridine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Dalfampridine Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Dalfampridine Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Dalfampridine Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Dalfampridine Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Dalfampridine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Dalfampridine Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Dalfampridine Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Dalfampridine Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Dalfampridine Sales by Country (2025-2030) & (K Units)
    Table 73. China Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 74. China Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 75. China Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 78. China Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 79. China Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Dalfampridine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Dalfampridine Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Dalfampridine Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Dalfampridine Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Dalfampridine Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Dalfampridine Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Dalfampridine Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Dalfampridine Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Dalfampridine Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Dalfampridine Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Dalfampridine Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Dalfampridine Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Dalfampridine Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Dalfampridine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Dalfampridine Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Dalfampridine Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Dalfampridine Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Dalfampridine Sales by Country (2025-2030) & (K Units)
    Table 107. Acorda Therapeutics Company Information
    Table 108. Acorda Therapeutics Description and Major Businesses
    Table 109. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Acorda Therapeutics Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Acorda Therapeutics Recent Developments
    Table 112. Elan Pharma Company Information
    Table 113. Elan Pharma Description and Major Businesses
    Table 114. Elan Pharma Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Elan Pharma Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Elan Pharma Recent Developments
    Table 117. Biogen Company Information
    Table 118. Biogen Description and Major Businesses
    Table 119. Biogen Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Biogen Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Biogen Recent Developments
    Table 122. Sun Pharmaceutical Company Information
    Table 123. Sun Pharmaceutical Description and Major Businesses
    Table 124. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Sun Pharmaceutical Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Sun Pharmaceutical Recent Developments
    Table 127. Aurobindo Pharma Company Information
    Table 128. Aurobindo Pharma Description and Major Businesses
    Table 129. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Aurobindo Pharma Dalfampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Aurobindo Pharma Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Dalfampridine Distributors List
    Table 135. Dalfampridine Customers List
    Table 136. Dalfampridine Market Trends
    Table 137. Dalfampridine Market Drivers
    Table 138. Dalfampridine Market Challenges
    Table 139. Dalfampridine Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dalfampridine Product Picture
    Figure 2. Global Dalfampridine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dalfampridine Market Share by Type in 2023 & 2030
    Figure 4. 10 mg Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Dalfampridine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Dalfampridine Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Dalfampridine Report Years Considered
    Figure 12. Global Dalfampridine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Dalfampridine Revenue 2019-2030 (US$ Million)
    Figure 14. Global Dalfampridine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Dalfampridine Revenue Market Share by Region (2019-2030)
    Figure 16. Global Dalfampridine Sales 2019-2030 ((K Units)
    Figure 17. Global Dalfampridine Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Dalfampridine Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Dalfampridine Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Dalfampridine Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Dalfampridine Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Dalfampridine Sales YoY (2019-2030) & (K Units)
    Figure 23. China Dalfampridine Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Dalfampridine Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Dalfampridine Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Dalfampridine Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Dalfampridine Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Dalfampridine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Dalfampridine in the World: Market Share by Dalfampridine Revenue in 2023
    Figure 30. Global Dalfampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 32. Global Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 33. Global Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 34. Global Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Dalfampridine Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Dalfampridine Sales Share by Country (2019-2030)
    Figure 41. U.S. Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 44. Europe Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 46. Europe Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Dalfampridine Revenue Share by Country (2019-2030)
    Figure 48. Europe Dalfampridine Sales Share by Country (2019-2030)
    Figure 49. Germany Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 50. France Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 54. China Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 55. China Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 56. China Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 57. China Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 59. Asia Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 61. Asia Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Dalfampridine Revenue Share by Region (2019-2030)
    Figure 63. Asia Dalfampridine Sales Share by Region (2019-2030)
    Figure 64. Japan Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 68. India Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Dalfampridine Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Dalfampridine Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Dalfampridine Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Dalfampridine Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Dalfampridine Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Dalfampridine Sales Share by Country (2019-2030)
    Figure 75. Brazil Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Dalfampridine Revenue (2019-2030) & (US$ Million)
    Figure 80. Dalfampridine Value Chain
    Figure 81. Dalfampridine Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Amifampridine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glatiramer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glatiramer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tiapride Market Insights Forecast to 2030
Global Anti Parkinson s Disease Drugs Market Research Report 2024
Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2030
Global Sulfapyridine Market Research Report 2024
Global Ticlopidine Market Research Report 2024
Global Ropinirole Market Insights Forecast to 2030
Glatiramer Acetate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Selegiline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Parkinson Drugs Market Insights Forecast to 2030
Global Cilnidipine API Market Research Report 2025
Global Armodafinil Tablets Market Research Report 2024
Global Fasudil Market Research Report 2024
Global Radicava Market Insights Forecast to 2030
Global Fingolimod Hydrochloride Market Research Report 2025
Global Parkinson Disease Drug Market Insights Forecast to 2030
Global Parkinson s Disease Treatment Market Insights Forecast to 2030
Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions